Luigi Di Biase, AF Symposium 2021: Current and Emerging Strategies for the Treatment of Persistent Atrial Fibrillation
We spoke to Dr Luigi Di Biase (Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA) on the current and new, emerging treatment strategies for the treatment of persistent atrial fibrillation, including the limitations of current pulmonary vein isolation, the concept of “beyond PVI” and clinical evidence supporting new ablation targets.
- What are the limitations of current pulmonary vein isolation (PVI) strategies in the treatment of persistent atrial fibrillation (AF)? (0:18)
- Could you give us an overview of the new and emerging ablation targets in persistent AF? (3:07)
- What do you feel complicates the concept of “beyond PVI”? (4:55)
- What clinical evidence supports approaches involving new ablation targets? (6:46)
Speaker disclosures: Dr Di Biase is a consultant for Biosense Webster, Stereoataxis and Rhythm management and has received speaker honoraria/travel support from Biosense Webster, St. Jude Medical (now Abbott), Boston Scientific, Medtronic, Biotronik, Pfizer and Bristol Meyers Squibb.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr Luigi Biase as a highlight of the AF Symposium, January 2021.
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!